there is extremely little known about the peptide, its benefits, and side effects
These receptor attribution studies established the MC4R-centric nature of central melanocortin sexual function biology
Phase 1a: First-in-Human Single Ascending Dose Study (NCT02951806) Study Title: "Safety, Tolerability, and Pharmacokinetics of Single Doses of Cagrilintide in Healthy Subjects" Status: Completed Phase: Phase 1a Enrollment: 48 healthy volunteers Study Period: 2016-2017 Location: Single center (Denmark) Design: Randomized, double-blind, placebo-controlled, single ascending dose Dose Range: 0.03-10 mg SC Primary Endpoints: Safety, tolerability, PK parameters Population: Healthy male subjects, BMI 20-28 Key Results: Pharmacokinetics: Terminal half-life 5-7 days across dose range
"Ondansetron (Zofran) can be effective during the first 12 days," she says
Dihexas unique structure allows it to cross the bloodbrain barrier and interact with pathways associated with brain performance and plasticity, making it a compound of interest in ongoing neurological research
What to do about it: Nothing